The nocebo effect: a clinical challenge in the era of biosimilars

Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes

(2018) Hillel P. Cohen et al.   DRUGS

The nocebo effect challenges the non-medical infliximab switch in practice

(2018) N. W. Boone et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, France

(2018) Jérôme Avouac et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Native mass spectrometry combined with enzymatic dissection unravels glycoform heterogeneity of biopharmaceuticals

(2018) Therese Wohlschlager et al.   Nature Communications

Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease

(2017) Federico Argüelles-Arias et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Clinical Predictors of Future Nonadherence in Inflammatory Bowel Disease

(2017) Mirjam Severs et al.   INFLAMMATORY BOWEL DISEASES

The Iatrogenic Potential of the Physician’s Words

(2017) Arthur J. Barsky   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial

(2017) Kristin K Jørgensen et al.   LANCET

Switching maintenance infliximab therapy to biosimilar infliximab in inflammatory bowel disease patients

(2017) Anja Eberl et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

The effects of treatment failure generalize across different routes of drug administration

(2017) Matthias Zunhammer et al.   Science Translational Medicine

Bad news: The influence of news coverage and Google searches on Gardasil adverse event reporting

(2017) Kate Faasse et al.   VACCINE

Subjective Complaints as the Main Reason for Biosimilar Discontinuation After Open-Label Transition From Reference Infliximab to Biosimilar Infliximab

(2017) Lieke Tweehuysen et al.   Arthritis & Rheumatology

Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians

(2016) Hillel Cohen et al.   ADVANCES IN THERAPY

A systematic review of factors that contribute to nocebo effects.

(2016) Rebecca K. Webster et al.   HEALTH PSYCHOLOGY

Patient Perspectives on Biosimilars: A Survey by the European Federation of Crohn’s and Ulcerative Colitis Associations: Table 1.

(2016) Laurent Peyrin-Biroulet et al.   Journal of Crohns & Colitis

Non-adherence to Anti-TNF Therapy is Associated with Illness Perceptions and Clinical Outcomes in Outpatients with Inflammatory Bowel Disease: Results from a Prospective Multicentre Study

(2016) Mike van der Have et al.   Journal of Crohns & Colitis

ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease—An Update

(2016) Silvio Danese et al.   Journal of Crohns & Colitis

Clinical Outcomes Following a Switch from Remicade® to the Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: A Prospective Observational Cohort Study

(2016) Lisa J. T. Smits et al.   Journal of Crohns & Colitis

Biosimilars in IBD: from theory to practice

(2016) Silvio Danese et al.   Nature Reviews Gastroenterology & Hepatology

Patient attitudes and understanding about biosimilars: an international cross-sectional survey

(2016) Ira Jacobs et al.   Patient Preference and Adherence

Switching Between Infliximab Originator and Biosimilar in Paediatric Patients with Inflammatory Bowel Disease. Preliminary Observations

(2015) J. Sieczkowska et al.   Journal of Crohns & Colitis

Distinct neural representations of placebo and nocebo effects

(2015) Sonya Freeman et al.   NEUROIMAGE

Placebo Responses to Original vs Generic ASA Brands During Exposure to Noxious Heat: A Pilot fMRI Study of Neurofunctional Correlates

(2015) Kai Fehse et al.   PAIN MEDICINE

Association Between Placebo-Activated Neural Systems and Antidepressant Responses

(2015) Marta Peciña et al.   JAMA Psychiatry

Avoiding Nocebo Effects to Optimize Treatment Outcome

(2014) Ulrike Bingel   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pain and the context

(2014) Elisa Carlino et al.   Nature Reviews Rheumatology

Specifying the nonspecific components of acupuncture analgesia

(2013) Lene Vase et al.   PAIN

The nocebo effect: patient expectations and medication side effects

(2013) Kate Faasse et al.   POSTGRADUATE MEDICAL JOURNAL

Nocebo in clinical trials for depression: A meta-analysis

(2013) Dimos D. Mitsikostas et al.   PSYCHIATRY RESEARCH

To Tell the Truth, the Whole Truth, May Do Patients Harm: The Problem of the Nocebo Effect for Informed Consent

(2012) Rebecca Erwin Wells et al.   AMERICAN JOURNAL OF BIOETHICS

Framing for Success: Nocebo Effects in Thoracic Surgery

(2012) Judson B. Williams et al.   ANNALS OF THORACIC SURGERY

The nocebo effect: A clinicians guide

(2012) João Data-Franco et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia

(2012) Marco DiBonaventura et al.   BMC Psychiatry

A direct test of the influence of nicotine response expectancies on the subjective and cognitive effects of smoking.

(2012) Paul T. Harrell et al.   EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY

Nocebo Effects, Patient-Clinician Communication, and Therapeutic Outcomes

(2012) Luana Colloca et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Effect of an Apparent Change to a Branded or Generic Medication on Drug Effectiveness and Side Effects

(2012) Kate Faasse et al.   PSYCHOSOMATIC MEDICINE

Contagious itch in humans: a study of visual ‘transmission’ of itch in atopic dermatitis and healthy subjects

(2011) A.D.P. Papoiu et al.   BRITISH JOURNAL OF DERMATOLOGY

Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches

(2011) Dimos D Mitsikostas et al.   CEPHALALGIA

A meta-analytic approach to estimating nocebo effects in neuropathic pain trials

(2011) Dimitrios Papadopoulos et al.   JOURNAL OF NEUROLOGY

On the importance of placebo timing in rTMS studies for pain relief

(2011) Nathalie André-Obadia et al.   PAIN

The Nocebo Effect and Its Relevance for Clinical Practice

(2011) Luana Colloca et al.   PSYCHOSOMATIC MEDICINE

Do mobile phone base stations affect sleep of residents? Results from an experimental double-blind sham-controlled field study

(2010) Heidi Danker-Hopfe et al.   AMERICAN JOURNAL OF HUMAN BIOLOGY

Nocebo-Induced Hyperalgesia During Local Anesthetic Injection

(2010) Dirk Varelmann et al.   ANESTHESIA AND ANALGESIA

The effects of observation and gender on psychogenic symptoms.

(2010) Giuliana Mazzoni et al.   HEALTH PSYCHOLOGY

Polluted places or polluted minds? An experimental sham-exposure study on background psychological factors of symptom formation in ‘Idiophatic Environmental Intolerance attributed to electromagnetic fields’

(2010) Renáta Szemerszky et al.   INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH

Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer

(2009) Maxine de la Cruz et al.   CANCER

Caffeine expectancies influence the subjective and behavioral effects of caffeine

(2009) Paul T. Harrell et al.   PSYCHOPHARMACOLOGY

Placebo and Nocebo Effects Are Defined by Opposite Opioid and Dopaminergic Responses

(2008) David J. Scott et al.   ARCHIVES OF GENERAL PSYCHIATRY